[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$otskf Graphic](https://lunarcrush.com/gi/w:26/t:$otskf.png) $otskf

FDA rejects Otsuka's PTSD program, while Mizuho and Jefferies offer positive outlooks. Otsuka acquires an autoimmune antibody, sparking mixed reactions.

### About $otskf
OTSKF is the stock ticker for Otsuka Pharmaceutical, a pharmaceutical company.  

### Insights [#](/topic/$otskf/insights)
- $otskf creators is up XXX% from the previous week.
- $otskf mentions is up XXX% from the previous week.

### Engagements: XXXXX [#](/topic/$otskf/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$otskf/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$otskf/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXX  
**1 Month**: XXXXX +207%  
**1-Year High**: XXXXX on 2025-07-18  
**1-Year Low**: X on 2025-07-03  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: X [#](/topic/$otskf/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$otskf/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$otskf/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X +400%  
**1 Month**: X +200%  
**1-Year High**: X on 2025-07-18  
**1-Year Low**: X on 2025-06-02  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$otskf/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$otskf/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$otskf/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $otskf in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X +200%  
**1 Month**: X +200%  
**1-Year High**: X on 2025-07-18  
**1-Year Low**: X on 2025-06-02  

**Top assets mentioned**
In the posts about $otskf in the last XX hours

[Biogen Inc (BIIB)](/topic/$biib)
[Vertex Protocol (VRTX)](/topic/$vrtx)
[Vertex Protocol (VRTX)](/topic/vertex-protocol)

**Top topics mentioned**
In the posts about $otskf in the last XX hours

[$axsms](/topic/$axsms), [$13bn](/topic/$13bn), [$biib](/topic/$biib), [$avxl](/topic/$avxl), [$jbios](/topic/$jbios), [$vrtx](/topic/$vrtx), [$jbio](/topic/$jbio), [vertex protocol](/topic/vertex-protocol), [$4768t](/topic/$4768t), [$4578t](/topic/$4578t), [$ipxhf](/topic/$ipxhf), [$asglf](/topic/$asglf), [$koscf](/topic/$koscf), [$smfrf](/topic/$smfrf), [$mrskf](/topic/$mrskf)

### Top Social Posts [#](/topic/$otskf/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Citing lack of evidence FDA panel votes against Otsuka's PTSD programme $OTSKF"  
[@fwpharma](/creator/x/fwpharma) on [X](/post/tweet/1946411492573688008) 2025-07-19 03:27:17 UTC 55.1K followers, XXX engagements


"Mizuho reiterated $AXSM Outperform-$210: $ALKS $ACAD $OTSKF $AVXL $BIIB "Next Monday AXSM will host an R&D Day to showcase its late-stage CNS pipeline which consists of four assets (AXS-05 AXS-12 AXS-14 and solriamfetol) being developed across eight indications and representing (per management guidance) an incremental peak revenue opp'y of$6-$13bn. From a stock perspective we're not necessarily expecting the event to serve as a significant catalyst but that said as we eagerly await an update on AXS-05/Auvelity in Alzheimer's disease agitation/ADA (easily the company's most important pipeline"  
[@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1946229225104556161) 2025-07-18 15:23:01 UTC 3519 followers, 1309 engagements


"Otsuka snaps up autoimmune antibody from Swedish biotech $OTSKF"  
[@fwpharma](/creator/x/fwpharma) on [X](/post/tweet/1945239393553240347) 2025-07-15 21:49:46 UTC 55.1K followers, XXX engagements


"Jefferies🏁 $JBIO Buy-$16 $VRTX $OTSKF Jefferies said in its initiation report: "We like $JBIO's long-acting anti-APRIL (JADE101) in IgAN: 1) our PK work suggests '101 can achieve Q8/12W dosing 2) we think efficacy will be as good as povetacicept w/ pot'l upside on % clinical remission 3) we expect tolerable safety profile w/o increased serious infections 4) we see oppty for disease modifying tx w/ longer dosing interval in IgAN. We model $915M risk-adj. PS for '101 (POS 30%). Co also has $255M cash/cash eq. w/ runway to '27.""  
[@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1944835951676494032) 2025-07-14 19:06:38 UTC 3517 followers, 1061 engagements